Assessing liver disease in cyanotic CHD using multiparametric MRI: a call to prevent future burden
The potential burden of CHD-related hepatic injury and steatotic liver disease highlights the importance of early identification. Given the possible additional risk of liver fibrosis in patients with coexisting metabolic dysfunction and CHD, comprehensive clinical management should prioritise regular metabolic risk assessment and the promotion of a healthy lifestyle to reduce the likelihood of liver disease development in this vulnerable population.
Authors
- Ana Maria Pittella (ORCID: https://orcid.org/0000-0002-8761-179X)
- Renata Perez
- Isabela M. T. Rangel
- Daniella Coelho Parente
- Fernanda Pimenta Fernandes (ORCID: https://orcid.org/0009-0000-9556-9651)
- Gabriel Camargo (ORCID: https://orcid.org/0000-0001-5203-6097)
- Ronir Raggio Luiz (ORCID: https://orcid.org/0000-0002-7784-9905)
- Igor Costermani
- A Innocenzi
- Andréa Silvestre-Sousa
- Rosana Souza Rodrigues
- Rosa Célia P. Barbosa
- Emiliano Medei
- Flávia V.O. Terzi
- José Carlos P. Secco
Institutions
- Universidade Federal do Rio de Janeiro (BR)
- Pro Criança Cardíaca (BR)
- D’Or Institute for Research and Education (BR)
- Faculdades Oswaldo Cruz (BR)
- Clínica Santa María (CO)
- Fundação Oswaldo Cruz (BR)
Publication Details
- Journal
- Cardiology in the Young
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1017/s1047951125110792
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35